Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,654 | 209 | 98.5% |
| Education | $56.69 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,111 | 71 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $797.53 | 36 | $0 (2024) |
| ABBVIE INC. | $275.80 | 22 | $0 (2024) |
| Alkermes, Inc. | $245.89 | 14 | $0 (2024) |
| Indivior Inc. | $146.03 | 10 | $0 (2024) |
| ITI, Inc. | $134.82 | 5 | $0 (2023) |
| Lundbeck LLC | $106.36 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $101.84 | 7 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $94.27 | 4 | $0 (2024) |
| Bausch Health US, LLC | $90.88 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $899.55 | 56 | Otsuka America Pharmaceutical, Inc. ($289.65) |
| 2023 | $429.65 | 27 | Otsuka America Pharmaceutical, Inc. ($148.13) |
| 2022 | $305.39 | 17 | Janssen Pharmaceuticals, Inc ($98.02) |
| 2021 | $304.32 | 16 | Janssen Pharmaceuticals, Inc ($81.31) |
| 2020 | $157.49 | 10 | Janssen Pharmaceuticals, Inc ($77.06) |
| 2019 | $875.79 | 38 | Janssen Pharmaceuticals, Inc ($427.01) |
| 2018 | $393.48 | 25 | Otsuka America Pharmaceutical, Inc. ($217.91) |
| 2017 | $344.97 | 24 | Otsuka America Pharmaceutical, Inc. ($190.84) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: ADHD | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $39.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $25.47 | General |
| 07/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Neuropsychiatry | ||||||
| 07/17/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 225 | 549 | $60,748 | $26,402 |
| 2022 | 6 | 323 | 871 | $110,795 | $54,669 |
| 2021 | 8 | 449 | 925 | $126,255 | $62,839 |
| 2020 | 7 | 469 | 893 | $118,745 | $60,624 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 127 | $19,050 | $9,093 | 47.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 59 | 121 | $14,520 | $5,587 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 82 | $9,840 | $5,124 | 52.1% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2023 | 15 | 57 | $10,260 | $4,730 | 46.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 48 | 162 | $7,078 | $1,867 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 385 | $57,800 | $32,099 | 55.5% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2022 | 45 | 114 | $20,520 | $9,539 | 46.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 49 | 119 | $14,280 | $5,774 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 45 | $5,370 | $2,723 | 50.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 45 | 77 | $6,930 | $2,663 | 38.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 26 | 131 | $5,895 | $1,869 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 277 | $41,550 | $24,122 | 58.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 41 | 105 | $21,000 | $14,144 | 67.4% |
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 55 | 91 | $16,380 | $8,197 | 50.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 83 | $9,960 | $5,521 | 55.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 59 | 93 | $11,160 | $4,778 | 42.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 68 | 90 | $8,160 | $2,617 | 32.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 26 | 139 | $6,295 | $2,091 | 33.2% |
| 99224 | Subsequent observation care, typically 15 minutes per day | Facility | 2021 | 21 | 47 | $11,750 | $1,368 | 11.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 66 | 169 | $33,800 | $22,490 | 66.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 116 | 201 | $30,150 | $15,959 | 52.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 101 | 205 | $24,600 | $10,345 | 42.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 96 | 144 | $17,280 | $6,362 | 36.8% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 20 | 34 | $6,120 | $3,167 | 51.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 59 | 129 | $5,805 | $1,923 | 33.1% |
About Dr. Alberto Gonzalez, MD
Dr. Alberto Gonzalez, MD is a Psychiatry healthcare provider based in Orangeburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487677696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alberto Gonzalez, MD has received a total of $3,711 in payments from pharmaceutical and medical device companies, with $899.55 received in 2024. These payments were reported across 213 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,654).
As a Medicare-enrolled provider, Gonzalez has provided services to 1,466 Medicare beneficiaries, totaling 3,238 services with total Medicare billing of $204,533. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Orangeburg, SC
- Active Since 07/26/2006
- Last Updated 04/30/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487677696
Products in Payments
- ABILIFY MAINTENA (Drug) $609.93
- SPRAVATO (Drug) $512.37
- REXULTI (Drug) $418.08
- VRAYLAR (Drug) $299.73
- INVEGA SUSTENNA (Drug) $249.66
- CAPLYTA (Drug) $170.80
- PERSERIS (Drug) $146.03
- ABILIFY ASIMTUFII (Drug) $123.18
- APLENZIN (Drug) $90.88
- Adzenys XR-ODT (Drug) $89.19
- ARISTADA (Drug) $88.65
- Xelstrym (Drug) $80.48
- AUSTEDO (Drug) $73.99
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $71.14
- LYBALVI (Drug) $68.59
- Aristada 441 mg (Drug) $65.64
- TRINTELLIX (Drug) $51.09
- INGREZZA (Drug) $40.61
- INVEGA TRINZA (Drug) $35.50
- FANAPT (Drug) $30.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Orangeburg
Dr. Russell Tobe, Md, MD
Psychiatry — Payments: $45,228
Dr. Joshua Kantrowitz, M.d, M.D
Psychiatry — Payments: $20,180
Ralph Nixon, M.d, M.D
Psychiatry — Payments: $4,985
Dr. Lina Haber, M.d, M.D
Psychiatry — Payments: $3,660
Anthony Sciarrone, Md, MD
Psychiatry — Payments: $3,195
Noshin Chowdhury, M.d, M.D
Psychiatry — Payments: $2,605